Title : The scopolamine model as a pharmacodynamic marker in early drug development - Lenz_2012_Psychopharmacology.(Berl)_220_97 |
Author(s) : Lenz RA , Baker JD , Locke C , Rueter LE , Mohler EG , Wesnes K , Abi-Saab WM , Saltarelli MD |
Ref : Psychopharmacology (Berl) , 220 :97 , 2012 |
Abstract : |
PubMedSearch : Lenz_2012_Psychopharmacology.(Berl)_220_97 |
PubMedID: 21901320 |
Title : Poster: Positive allosteric modulation of alpha4\/beta2 nicotinic receptors potentiates some CNS effects of the alpha4\/beta2 agonist, ABT-594 - |
Author(s) : Franklin SR , Mohler EG , Komater VA , Robb H , Radek RJ , Rustay NR , Brown JW , Gopalakrishnan M , Decker MW , Rueter LE |
Ref : Biochemical Pharmacology , 78 :921 , 2009 |
PubMedID: |
Title : VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux - Mohler_2007_Neuropharmacol_53_563 |
Author(s) : Mohler EG , Shacham S , Noiman S , Lezoualc'h F , Robert S , Gastineau M , Rutkowski J , Marantz Y , Dumuis A , Bockaert J , Gold PE , Ragozzino ME |
Ref : Neuropharmacology , 53 :563 , 2007 |
Abstract : |
PubMedSearch : Mohler_2007_Neuropharmacol_53_563 |
PubMedID: 17692343 |